Drug Shortage Report for PMS-MIRTAZAPINE
Report ID | 10680 |
Drug Identification Number | 02248762 |
Brand name | PMS-MIRTAZAPINE |
Common or Proper name | MIRTAZAPINE |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | MIRTAZAPINE |
Strength(s) | 30MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-07-05 |
Actual start date | 2017-07-05 |
Estimated end date | 2019-02-20 |
Actual end date | 2019-02-25 |
Shortage status | Resolved |
Updated date | 2019-02-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-05-18 | English | Compare |